Product Code: GVR-4-68040-121-6
Catheter Introducer Sheaths Market Growth & Trends:
The global catheter introducer sheaths market size is estimated to reach USD 1.93 billion by 2030, registering to grow at a CAGR of 7.5% from 2025 to 2030 according to a new report by Grand View Research, Inc. The growth is attributed to the increasing investment by major players in the market for the development of technologically advanced catheter introducer sheaths. Advancements in these sheaths make them more compatible and safe owing to reduced friction, smaller incision diameter, and increased flexibility.
The COVID-19 pandemic initially disrupted the catheter introducer sheaths industry due to supply chain challenges, decreased elective procedures, and healthcare resource reallocation. As the pandemic progressed, increased focus on infection control and minimally invasive interventions drove demand for advanced, safer, and more efficient sheath designs. While short-term setbacks were observed, the pandemic ultimately spurred innovation and reshaped the market toward more resilient and patient-centered solutions.
Personalized medicine and 3D printing have emerged, allowing customized sheaths tailored to individual patient anatomies. In addition, regulatory compliance and standardization efforts are shaping the market's future, ensuring product safety and efficacy. Moreover, the increasing prevalence of cardiovascular disorders and the rising geriatric population fuel the market growth.According to a study conducted by NCBI in 2022, atrial fibrillation is expected to affect 19.6% of patients over 65 years of age by 2030, and this estimation is expected to double by 2050. Furthermore, according to the CDC, atrial fibrillation is expected to affect 12.1 million people in the U.S. by the end of 2030.
Catheter Introducer Sheaths Market Report Highlights:
- The integrated introducer sheaths segment held the largest share of over 60.2% in 2024 due to the increasing prevalence of CVD and technological advancements. Integrated introducer sheaths are single-unit devices designed to provide smooth and continuous access for catheter insertion during medical procedures.
- The hospitals segment held the largest share at 59.5% in 2024. As healthcare facilities expand their capabilities and adopt advanced technologies, the need for reliable and effective introducer sheaths rises, driving the catheter introducer sheaths industry.
- North America dominated the catheter introducer sheaths market with a share of 37.1% in 2024, owing to an increased prevalence of CVD and the rising demand for surgical procedures and technological advancements.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. End use
- 1.2.3. Regional scope
- 1.2.4. Estimates and forecast timeline.
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity price analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Segment
- 2.2.2. End use Segment
- 2.2.3. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Global Catheter Introducer Sheaths Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Growing prevalence of CVDs
- 3.2.1.2. Increasing cardiac surgical procedures
- 3.2.1.3. Increased government initiatives
- 3.2.1.4. Technological advancements
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost associated with catheter introducer sheath
- 3.3. Catheter Introducer Sheaths Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Catheter Introducer Sheaths Market: Product Estimates & Trend Analysis
- 4.1. Catheter Introducer Sheaths Market: Product Dashboard
- 4.2. Catheter Introducer Sheaths Market: Product Movement Analysis
- 4.3. Catheter Introducer Sheaths Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Integrated Introducer Sheaths
- 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.5. Separable Introducer Sheaths
- 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Catheter Introducer Sheaths Market: End use Estimates & Trend Analysis
- 5.1. Catheter Introducer Sheaths Market: End use Dashboard
- 5.2. Catheter Introducer Sheaths Market: End use Movement Analysis
- 5.3. Catheter Introducer Sheaths Market Size & Forecasts and Trend Analysis, by End use, 2018 to 2030 (USD Million)
- 5.4. Hospitals
- 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.5. Ambulatory surgical centers
- 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.6. Others
- 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Catheter Introducer Sheaths Market: Regional Estimates & Trend Analysis by Product, End use, and Region
- 6.1. Global Catheter Introducer Sheaths Market: Regional Dashboard
- 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
- 6.3. North America
- 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Key country dynamics
- 6.3.2.2. Regulatory framework/ reimbursement structure
- 6.3.2.3. Competitive scenario
- 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.3. Canada
- 6.3.3.1. Key country dynamics
- 6.3.3.2. Regulatory framework/ reimbursement structure
- 6.3.3.3. Competitive scenario
- 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.4. Mexico
- 6.3.4.1. Key country dynamics
- 6.3.4.2. Regulatory framework/ reimbursement structure
- 6.3.4.3. Competitive scenario
- 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4. Europe
- 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.4.2. UK
- 6.4.2.1. Key country dynamics
- 6.4.2.2. Regulatory framework/ reimbursement structure
- 6.4.2.3. Competitive scenario
- 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.3. Germany
- 6.4.3.1. Key country dynamics
- 6.4.3.2. Regulatory framework/ reimbursement structure
- 6.4.3.3. Competitive scenario
- 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.4. France
- 6.4.4.1. Key country dynamics
- 6.4.4.2. Regulatory framework/ reimbursement structure
- 6.4.4.3. Competitive scenario
- 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.5. Italy
- 6.4.5.1. Key country dynamics
- 6.4.5.2. Regulatory framework/ reimbursement structure
- 6.4.5.3. Competitive scenario
- 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.6. Spain
- 6.4.6.1. Key country dynamics
- 6.4.6.2. Regulatory framework/ reimbursement structure
- 6.4.6.3. Competitive scenario
- 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.7. Sweden
- 6.4.7.1. Key country dynamics
- 6.4.7.2. Regulatory framework/ reimbursement structure
- 6.4.7.3. Competitive scenario
- 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.8. Norway
- 6.4.8.1. Key country dynamics
- 6.4.8.2. Regulatory framework/ reimbursement structure
- 6.4.8.3. Competitive scenario
- 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.9. Denmark
- 6.4.9.1. Key country dynamics
- 6.4.9.2. Regulatory framework/ reimbursement structure
- 6.4.9.3. Competitive scenario
- 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5. Asia Pacific
- 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5.2. China
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Regulatory framework/ reimbursement structure
- 6.5.2.3. Competitive scenario
- 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.3. Japan
- 6.5.3.1. Key country dynamics
- 6.5.3.2. Regulatory framework/ reimbursement structure
- 6.5.3.3. Competitive scenario
- 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.4. India
- 6.5.4.1. Key country dynamics
- 6.5.4.2. Regulatory framework/ reimbursement structure
- 6.5.4.3. Competitive scenario
- 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.5. Australia
- 6.5.5.1. Key country dynamics
- 6.5.5.2. Regulatory framework/ reimbursement structure
- 6.5.5.3. Competitive scenario
- 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.6. Thailand
- 6.5.6.1. Key country dynamics
- 6.5.6.2. Regulatory framework/ reimbursement structure
- 6.5.6.3. Competitive scenario
- 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.7. South Korea
- 6.5.7.1. Key country dynamics
- 6.5.7.2. Regulatory framework/ reimbursement structure
- 6.5.7.3. Competitive scenario
- 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6. Latin America
- 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.6.2. Brazil
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Regulatory framework/ reimbursement structure
- 6.6.2.3. Competitive scenario
- 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6.3. Argentina
- 6.6.3.1. Key country dynamics
- 6.6.3.2. Regulatory framework/ reimbursement structure
- 6.6.3.3. Competitive scenario
- 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7. MEA
- 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.7.2. Saudi Arabia
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Regulatory framework/ reimbursement structure
- 6.7.2.3. Competitive scenario
- 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.3. South Africa
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Regulatory framework/ reimbursement structure
- 6.7.3.3. Competitive scenario
- 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.4. UAE
- 6.7.4.1. Key country dynamics
- 6.7.4.2. Regulatory framework/ reimbursement structure
- 6.7.4.3. Competitive scenario
- 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.5. Kuwait
- 6.7.5.1. Key country dynamics
- 6.7.5.2. Regulatory framework/ reimbursement structure
- 6.7.5.3. Competitive scenario
- 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Key company market share analysis, 2024
- 7.3.4. Terumo Corporation
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. Merit Medical
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Medtronic
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. Galt Medical Corporation
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. Cordis Corporation
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. Oscor Inc
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Product benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. Abbott
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Product benchmarking
- 7.3.10.4. Strategic initiatives
- 7.3.11. Stryker
- 7.3.11.1. Company overview
- 7.3.11.2. Financial performance
- 7.3.11.3. Product benchmarking
- 7.3.11.4. Strategic initiatives
- 7.3.12. BD
- 7.3.12.1. Company overview
- 7.3.12.2. Financial performance
- 7.3.12.3. Product benchmarking
- 7.3.12.4. Strategic initiatives
- 7.3.13. B. Braun Interventional Systems Inc.
- 7.3.13.1. Company overview
- 7.3.13.2. Financial performance
- 7.3.13.3. Product benchmarking
- 7.3.13.4. Strategic initiatives